ProfileGDS4718 / 201910_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 79% 81% 96% 77% 81% 92% 86% 80% 81% 80% 80% 75% 82% 89% 84% 81% 77% 87% 76% 92% 76% 76% 80% 78% 77% 93% 80% 89% 84% 89% 82% 94% 80% 77% 87% 88% 76% 82% 81% 97% 83% 91% 88% 84% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.6867279
GSM549102patient 115, normal, homogenized [OPG study]7.9486681
GSM549104patient 119, normal, homogenized [OPG study]10.504896
GSM549108patient 138, normal, homogenized [OPG study]7.4264777
GSM549119patient 077, normal, homogenized [OPG study]7.9673881
GSM549133patient 032, cancer, homogenized [OPG study]9.6082692
GSM549139patient 042, cancer, homogenized [OPG study]8.6604586
GSM549099patient 107, normal, homogenized [OPG study]7.7293680
GSM549109patient 139, normal, homogenized [OPG study]7.8511281
GSM549110patient 046, normal, homogenized [OPG study]7.8425480
GSM549114patient 063, normal, homogenized [OPG study]7.8619180
GSM549122patient 082, normal, homogenized [OPG study]7.361975
GSM549134patient 033, cancer, homogenized [OPG study]8.1673682
GSM549136patient 036, cancer, homogenized [OPG study]9.1100689
GSM549140patient 044, cancer, homogenized [OPG study]8.4066484
GSM549111patient 047, normal, homogenized [OPG study]8.0011881
GSM549113patient 057, normal, homogenized [OPG study]7.5789477
GSM549132patient 031, cancer, homogenized [OPG study]8.7883487
GSM549137patient 038, cancer, homogenized [OPG study]7.4996576
GSM549142patient 047, cancer, homogenized [OPG study]9.0678992
GSM549100patient 110, normal, homogenized [OPG study]7.3964976
GSM549107patient 135, normal, homogenized [OPG study]7.4464276
GSM549115patient 068, normal, homogenized [OPG study]7.9526180
GSM549116patient 072, normal, homogenized [OPG study]7.6312678
GSM549120patient 078, normal, homogenized [OPG study]7.517377
GSM549131patient 030, cancer, homogenized [OPG study]9.8705293
GSM549118patient 074, normal, homogenized [OPG study]7.8971480
GSM549129patient 027, cancer, homogenized [OPG study]8.9310789
GSM549123patient 088, normal, homogenized [OPG study]8.3296984
GSM549124patient 006, cancer, homogenized [OPG study]8.8242889
GSM549126patient 015, cancer, homogenized [OPG study]8.0994882
GSM549128patient 025, cancer, homogenized [OPG study]9.8409694
GSM549103patient 117, normal, homogenized [OPG study]7.6918480
GSM549117patient 073, normal, homogenized [OPG study]7.5450477
GSM549138patient 041, cancer, homogenized [OPG study]8.8147887
GSM549141patient 045, cancer, homogenized [OPG study]8.9545588
GSM549130patient 028, cancer, homogenized [OPG study]7.454176
GSM549101patient 111, normal, homogenized [OPG study]8.0501582
GSM549105patient 128, normal, homogenized [OPG study]7.9134881
GSM549106patient 134, normal, homogenized [OPG study]10.884297
GSM549112patient 048, normal, homogenized [OPG study]8.1952183
GSM549125patient 011, cancer, homogenized [OPG study]9.2875791
GSM549127patient 024, cancer, homogenized [OPG study]8.8254388
GSM549135patient 035, cancer, homogenized [OPG study]8.483884